Extra Space Storage (EXR) 2026 stock analysis: self-storage location and pricing-algorithm moat, Life Storage merger integration, REIT interest-rate sensitivity, and the new-supply glut reshaping same-store growth.
Robostar (090360) 2026 stock outlook. A deep look at the Korean industrial-robot maker's Cartesian and SCARA lineup, its captive demand from LG's battery and display supply chains, humanoid-component theme exposure, and the double edge of relying on a single corporate parent.
Snap-on (NYSE: SNA) 2026 stock outlook. A deep look at the mobile van franchise model, Snap-on Credit's recurring finance income, diagnostics growth, technician-confidence cyclicality, EV repair-mix shift, and its dividend-growth quality.
Martin Marietta Materials (MLM) 2026 stock analysis: the local-monopoly economics of construction aggregates, the bolt-on acquisition playbook, infrastructure and data-center demand tailwinds, competition from Vulcan Materials and CRH, and the real cyclical risks.
Seojin System (178320) 2026 stock outlook. A deep look at its vertically integrated aluminum enclosure business, Vietnam manufacturing cost edge, leverage to ESS and AI-server and telecom demand, plus customer-concentration, aluminum-price, currency and balance-sheet risks.
Knight-Swift (KNX) 2026 stock analysis for US investors: the largest US truckload carrier, the freight recession bottoming thesis, operating ratio leverage on the recovery, the higher-margin LTL build-out, self-insurance and nuclear-verdict risk, plus peer comparison versus ODFL, JBHT, and Werner.
A qualitative deep-dive on Jeryong Electric (033100) for 2026: the U.S. aging-grid replacement wave, AI data-center power demand, the transformer supply bottleneck, its distribution-transformer product mix, the cyclical valuation trap, and how to tell where the cycle really stands.
PTC Inc (PTC) 2026 stock outlook covering the Creo-Windchill-ThingWorx digital thread, why net-new ARR now drives the stock more than headline revenue, competition from Siemens and Dassault, and manufacturing capex cycle risk.
Masimo (MASI) 2026 stock outlook. A deep look at the SET pulse oximetry moat, the razor-and-blade sensor model, the Sound United misstep, the Politan activist campaign and governance reset, and the Apple Watch ITC patent win.
ST Pharm (237690) 2026 stock outlook. A deep qualitative look at its world-leading oligonucleotide CDMO position, RNA-drug demand from inclisiran, siRNA and GLP-1-adjacent pipelines, Dong-A Socio group backing, and the capacity-expansion cycle that drives the shares.
Viatris (VTRS) 2026 stock outlook. A qualitative deep dive into the Pfizer Upjohn-Mylan merger, the debt paydown and dividend story, brand-revenue decline offset by complex generics and biosimilars, EpiPen's fading pricing power, and the key risks.
Cencora (COR, formerly AmerisourceBergen) 2026 stock analysis: the big-three pharma distribution oligopoly, razor-thin margins on enormous volume, specialty and GLP-1 tailwinds, opioid settlement drag, and Walgreens customer concentration risk.
HanAll Biopharma (009420) 2026 stock outlook. A deep qualitative look at the batoclimab FcRn autoimmune franchise, the Immunovant and Harbour BioMed out-licensing royalty and milestone structure, the tanfanercept dry-eye pipeline, Daewoong group synergy, clinical catalysts, and the risks a US investor should weigh.
MarketAxess (MKTX) 2026 stock analysis: the RFQ and Open Trading network effect, how its basis-point fee model actually works, the Tradeweb share battle, portfolio trading risk, and where the growth runway still exists.
BLDR (Builders FirstSource) 2026 stock outlook. A deep, qualitative look at the largest US building-materials distributor: fragmented-market roll-up M&A, prefab and value-added margin expansion, single-family housing-starts and rate sensitivity, lumber-price swings, and aggressive buybacks shrinking the float.
Boryung (003850) 2026 stock outlook. A deep, qualitative look at Korea's homegrown Kanarb antihypertensive franchise (Duokarb, Dukaro), the Legacy Brands Acquisition cash roll-up strategy, the Axiom Space optionality bet, drug-price and generic risk, and how foreign investors should frame a Korean mid-cap pharma.
Raymond James Financial (RJF) 2026 stock analysis: the independent advisor moat, net interest income exposure to falling rates, cash sorting risk, advisor recruiting economics, the TriState Capital deal, and how RJF stacks up against LPL and Schwab.
Casey's General Stores (CASY) 2026 stock analysis: how a Midwest rural convenience-store chain turns thin fuel margins into a scratch-made pizza and prepared-food profit engine, its build-plus-acquire unit growth model, EV transition risk, and how it stacks up against 7-Eleven and Circle K.
Jeisys Medical (287410) 2026 stock outlook. A deep qualitative look at its RF and HIFU energy-based devices, the recurring consumable-tip revenue model, POTENZA export momentum, the three-way fight with Classys and Wontech, ownership and M&A risk, and the metrics that actually move this KOSDAQ aesthetic name.
NRG Energy (NYSE: NRG) stock outlook for 2026. A deep, qualitative look at the retail electricity and Vivint smart-home subscription engine, competitive generation, AI data-center power demand re-rating dispatchable capacity, aggressive buybacks, and commodity, weather, and leverage risk.
Tractor Supply Company (TSCO) 2026 stock outlook: the small-town real estate moat, the C.U.E. consumables model, Petsense and in-store vet clinic expansion, weather-driven seasonality, and farm-income cycle risk explained qualitatively.
T'way Air (KOSPI 091810) 2026 stock outlook. An in-depth look at why a Korean low-cost carrier is flying long-haul to Europe and Australia, the Korean Air-Asiana merger windfall, the Daemyung Sono ownership fight, and the fuel, FX, and aircraft-lease risks that define the thesis.
Pentair (PNR) 2026 stock analysis: how pool equipment, residential water filtration, and municipal flow control combine in one company, the Hydra-Stop and Manitowoc Ice bolt-on acquisitions, a 48-year dividend growth streak, and the housing-cycle risk investors underweight.
Hyosung TNC (298020) 2026 stock outlook. A deep look at CREORA spandex global #1 pricing power, bio-based spandex and regen recycled-fiber premium, versus PTMEG/BDO raw-material costs, Chinese capacity additions, and apparel-demand cycles for the US investor.